Recent advances of field-effect transistor technology for infectious diseases
Field-effect transistor (FET) biosensors have been intensively researched toward label-free
biomolecule sensing for different disease screening applications. High sensitivity, incredible …
biomolecule sensing for different disease screening applications. High sensitivity, incredible …
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19
NA Makoah, T Tipih, MM Litabe, M Brink… - Future …, 2022 - Taylor & Francis
Aim: The aim of this study was to investigate the utility of serological tests for the diagnosis of
COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT …
COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT …
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals
A Ruggiero, C Piubelli, L Calciano, S Accordini… - …, 2022 - thelancet.com
Background Currently, evaluation of the IgG antibodies specific for the SARS-CoV-2 Spike
protein following vaccination is used worldwide to estimate vaccine response. Limited data …
protein following vaccination is used worldwide to estimate vaccine response. Limited data …
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
Rapid and accurate measurement of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity …
(SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity …
Microarray-based detection of antibodies against SARS-CoV-2 proteins, common respiratory viruses and type I interferons
E Savvateeva, M Filippova, V Valuev-Elliston… - Viruses, 2021 - mdpi.com
A microarray-based assay to detect IgG and IgM antibodies against betacoronaviruses
(SARS-CoV-2, SARS, MERS, OC43, and HKU1), other respiratory viruses and type I …
(SARS-CoV-2, SARS, MERS, OC43, and HKU1), other respiratory viruses and type I …
[HTML][HTML] Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD …
Background A vast majority of the commercially available lateral flow immunoassay (LFIA) is
used to detect SARS-CoV-2 antibodies qualitatively. Recently, a novel fluorescence-based …
used to detect SARS-CoV-2 antibodies qualitatively. Recently, a novel fluorescence-based …
The spike of SARS-CoV-2: uniqueness and applications
The Spike (S) protein of the SARS-CoV-2 virus is critical for its ability to attach and fuse into
the host cells, leading to infection, and transmission. In this review, we have initially …
the host cells, leading to infection, and transmission. In this review, we have initially …
[HTML][HTML] Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana
PK Quashie, JK Mutungi… - Wellcome Open …, 2021 - wellcomeopenresearch.org
Background: We set out to estimate the community-level exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in Ghana. Methods: Phased …
respiratory syndrome coronavirus 2 (SARS-CoV-2) in Ghana. Methods: Phased …
Utilization of a glucometer test strip and enzymatic reactions to quantify anti-SARS-CoV-2 spike RBD IgG antibody and SARS-CoV-2 virus in saliva and serum
A sensor capable of quantifying both anti-SARS-CoV-2 spike receptor-binding domain
(RBD) antibody levels and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
(RBD) antibody levels and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19
S Rezaeian, F Razmjooei, M Pourmokhtari, A Abdoli… - Heliyon, 2023 - cell.com
Background Different biomarkers have been suggested as novel biomarkers of coronavirus
disease 2019 (COVID-19) theragnosis. With the aim of having a better clinical management …
disease 2019 (COVID-19) theragnosis. With the aim of having a better clinical management …